HOME >> BIOLOGY >> NEWS
Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments

Irvine, Calif. - UC Irvine School of Medicine researchers have discovered how new neurons born from endogenous neural stem cells are sent to regions of the brain where they can replace old and dying cells, a finding that suggests how stem cell therapies can be specifically targeted to brain regions affected by neurodegenerative diseases or by stroke.

Associate Professor Qun-Yong Zhou and graduate student Kwan L. Ng in the UCI Department of Pharmacology have identified a protein that guides these new neurons to a particular brain region. The protein, a small peptide called prokineticin 2 (PK2), was found to play a key regulatory role for the proper functional integration of these new neurons in the brain. A few years ago, PK2 was shown by the same research group to be an important regulator of circadian rhythms. The current study appears in the June 24 issue of the journal Science.

"One of the keys to developing promising new therapies for debilitating neurodegenerative diseases lies in our understanding of how new neurons are created and integrated into mature brain tissue," Zhou said. "This protein is an attractive drug target for either boosting neuron-forming processes or stem cell-based therapies for diseases like Alzheimer's and Parkinson's, or for stroke and other brain injuries."

While all neurons are originally born and differentiated from their stem cell progenitors during development, the adult brain maintains at least some regions where neural stem cells create new neurons to replace old and dying ones. One area is the subventricular zone of the lateral ventricles, which are fluid-filled cavities in both brain hemispheres connected the central canal of the spinal cord.

Zhou and his colleagues discovered how PK2 guides the migration of neurons born from neural stem cells from the subventricular zone in the brain's core through mature tissue to reach the olfactory bulb, the "
'"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
23-Jun-2005


Page: 1 2

Related biology news :

1. Researchers find pathway that controls cell size and division
2. Researchers watch antibiotics, bacteria meet at atomic level
3. Researchers discover gene responsible for Restless Legs Syndrome
4. Researchers witness natural selection at work in dramatic comeback of male butterflies
5. Researchers discover human embryonic stem cells are the ultimate perpetual fuel cell
6. Researchers use new approach to predict protein function
7. Researchers probe risks, benefits of folic acid fortification
8. Researchers identify genetic mutation that may alter tumor cell proliferation
9. Researchers discover method for identifying how cancer evades the immune system
10. Researchers use adult stem cells to create soft tissue
11. Researchers find gene that spurs development of the epididymis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... 15, 2019 , ... Modality Solutions, a biopharmaceutical ... on the Houston Business Journal’s Fast 100 list. Modality Solutions ranked No. 91 ... in Houston, Modality Solutions is a biopharmaceutical cold chain engineering firm with regulatory ...
(Date:10/11/2019)... ... October 11, 2019 , ... ... surgeon, oncologist, and researcher Dr. Pavel Tyan has been appointed Therapeutic Lead for ... the organization, further enhancing the already strong scientific and delivery credentials previously offered ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... that make it easier than ever for businesses and organizations to use their ... App enables organizations to count down to or count up from date-related milestones, ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... is pleased to announce that it has moved into a new, 5000 sqft, ... instruments, the new facility demonstrates the company's continuous commitment to quality research and ...
(Date:9/24/2019)... Mass. (PRWEB) , ... September ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, a ... and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd ... Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney ...
Breaking Biology Technology:
Cached News: